About Chroma Medicine
Chroma Medicine develops single-dose genomic medicines that utilize epigenetics to regulate gene expression. By altering the structure of chromatin, the material that carries DNA, the company aims to create treatments that can lead to lasting changes in how genes are expressed, even as cells divide. This method allows for the control of gene expression without changing the DNA sequence itself, which could transform the treatment landscape for various diseases. Unlike many competitors, Chroma Medicine focuses specifically on this epigenetic approach, positioning itself in the biotechnology market with a unique business model centered on research and development. The goal is to create a new class of therapeutics that can effectively address diseases while also expanding the field of genomic medicine.